{"id":"aliskiren-perindopril","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperkalemia"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Cough"},{"rate":null,"effect":"Hypotension"}]},"_chembl":{"chemblId":"CHEMBL1581","moleculeType":"Small molecule","molecularWeight":"368.47"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Aliskiren is a direct renin inhibitor that blocks the first step of the renin-angiotensin cascade, while perindopril is an ACE inhibitor that prevents conversion of angiotensin I to angiotensin II. Together, they provide complementary inhibition of the pathway that regulates blood pressure and fluid balance, resulting in greater blood pressure reduction than either agent alone.","oneSentence":"This combination lowers blood pressure by blocking the renin-angiotensin-aldosterone system through dual inhibition of renin and ACE.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:26:58.128Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"}]},"trialDetails":[{"nctId":"NCT04467931","phase":"","title":"ACEI or ARB and COVID-19 Severity and Mortality in US Veterans","status":"COMPLETED","sponsor":"University of Utah","startDate":"2020-01-19","conditions":"Hypertension, COVID","enrollment":22213},{"nctId":"NCT01219413","phase":"PHASE4","title":"Influence of Aliskiren on Proteinuria","status":"COMPLETED","sponsor":"Medical University of Gdansk","startDate":"2009-03","conditions":"Chronic Kidney Disease, Proteinuria, Blood Pressure","enrollment":16}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":14,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Rasilez 300 mg","Prestarium 10 mg"],"phase":"marketed","status":"active","brandName":"Aliskiren, Perindopril","genericName":"Aliskiren, Perindopril","companyName":"Medical University of Gdansk","companyId":"medical-university-of-gdansk","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This combination lowers blood pressure by blocking the renin-angiotensin-aldosterone system through dual inhibition of renin and ACE. Used for Hypertension.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}